Screening of preformed oxidised low density lipoprotein isolated by a polyanion precipitation method. Its correlation with serum triglyceride levels

Pharmacological Research

Volumn 37, Issue 4, 1998, Pages 265-272

  Neuman, María P ^a   Montenero, Yolanda ^a   Neuman, Fernando J ^a   Bruetman, Julio ^a   Roccella, María C ^a   Neuman, José ^a  

^a Inst Privado de Enferm C   (Argentina)

Author keywords

Atherogenesis; HDL C; Lipid peroxides; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYANION; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032056015     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1998.0298     Document Type: Article

References (48)

1. 1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-24.
2. 2. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748-52.
3. 3. Steinberg D, and Workshop Participants. Antioxidants in the prevention of human atherosclerosis. Summary of the Proceedings of a National Heart, and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992; 85: 2338-44.
4. 4. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984; 74: 1890-4.
5. 5. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992; 13: 341-90.
6. 6. Morel DW, Chisolm GM. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 1989; 30: 1827-34.
7. 7. Avogaro P, Bittolo Bon G, Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988; 8: 79-87.
8. 8. Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J Lipid Res 1996; 37: 45-53.
9. 9. El Saadani M, Esterbauer H, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30: 627-30.
10. 10. Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clin Chim Acta 1984; 140: 77-83.
11. 11. Regnstrom J, Nilsson J, Tornvall P, Landou Ch, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-6.
12. 12. Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298-306.
13. 13. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content-of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981; 115: 155-61.
14. 14. Strapans I, Rapp JH, Pan XM, Kim KY, Feingold RK. Oxidized lipids in the diet are a source of oxidized 1 lipid in chylomicrons of human serum. Arterioscler Thromb 1994; 14: 1900-5.
15. 15. Demacker PN, Hijmans AG, Brenninkmeijer BJ, Jansen AP, van't Laar A. Five methods for determining low-density lipoprotein cholesterol compared. Clin Chem 1984; 30: 1797-800.
16. 2-cholesterol under prolonged simvastatin treatment. Atherosclerosis 1991; 91: S11-19.
17. 17. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997; 17: 1114-20.
18. 18. Sutherland WHF. Oxidation of heparin-isolated LDL by hemin. The effect of serum components. Arterioscler Thromb 1994; 14: 1966-75.
19. 19. Dujovne CA, Harris WS, Colle Gerrond LL, Fan J, Muzio F. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia. Am J Cardiol 1994; 74: 38-42.
20. 20. Chajes V, Sattler W, Stultschning M, Kostner GM. Photometric evaluation of lipid peroxidation products in human plasma and copper oxidized low density lipoproteins: correlation of different oxidation parameters. Atherosclerosis 1996; 121: 193-203.
21. 21. Esterbauer H, Jurgens G, Quehenberger O, Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987; 28: 495-509.
22. 22. Cramer GL, Miller JF, Pendleton RB, Lands WEM. Iodometric measurement of lipid hydroperoxides in human plasma. Anal Biochem 1991; 193: 204-11.
23. 23. Staprans I, Rapp JH, Pan XM, Feingold RK. The effect of oxidized lipids in the diet on serum lipoprotein peroxides in control and diabetic rats. J Clin Invest 1993; 92: 638-43.
24. 24. Koller E, Quehenberger O, Jurgens G, Wolfbeis OS, Esterbauer H. Investigation of human plasma low density lipoprotein by three-dimensional fluorescence spectroscopy. Febs Lett 1986; 198: 229-34.
25. 25. Morrow JD, Roberts J. Quantification of noncyclooxygenase derived prostanoids as a marker of oxidative stress. Free Rad Biol Med 1991; 10: 195-200.
26. 26. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd. Increase in circulating products of lipid peroxidation (F2-Isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-203.
27. 27. Mackness MI, Abbott C, Arrol S, Durrington PN. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem J 1993; 294: 829-34.
28. 3 enhances the protective action of ascorbic acid against LDL peroxidation. Abstracts Atherosclerosis X, Montreal: 1994; 52.
29. 29. Lavy A, Brook GJ, Dankner G, Ben Amotz A, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991; 40: 794-9.
30. 30. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C, Schemather G, et al. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 1995; 98: 469-75.
31. 31. Kawamura M, Heinecke JW, Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J Clin Invest 1994; 94: 771-8.
32. 32. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fraction of diabetic patients. Biochem Med 1981; 25: 373-8.
33. 33. Stringer MD, Gorog PG, Freeman A, Kakkar VV. Lipid peroxides and atherosclerosis. Br Med J 1989; 298: 281-4.
34. 34. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993; 88: 2762-70.
35. 35. Austin A, Breslow JL, Hennekens CH, Buring E, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 1988; 260: 1917-21.
36. 36. Parthasarathy S, Quinn MT, Schwenke DC, Carew TE, Steinberg D. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis 1989; 9: 398-404.
37. 37. Mohr D, Stoker E. Radical-mediated oxidation of isolated human very-low-density lipoprotein. Arterioscler Thromb 1994; 14: 1186-92.
38. 38. Carlson LA, Bottiger LE. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218: 207-11.
39. 39. Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PRO-CAM Experience). Am J Cardiol 1992; 70: 733-7.
40. 40. Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, De Backer G. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS Study. Circulation 1994; 89: 1967-73.
41. 41. Heinonen OP, Huttunen JK, Manninen V, Manttari M, Koskinen P, Tenkanen L, Frick MH. The Helsinki Heart Study 1: Coronary heart disease incidence during an extended follow-up. J Intern Med 1994; 235: 41-9.
42. 42. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel II). J Am Med Assoc 1993; 269: 3015-23.
43. 43. Ishikawa Y, Inadera H, Shirai K, Hashimoto H, Fukamachi I, Saito Y, Yoshida S. Moderate oxidation of hypertriglyceridemic low-density lipoprotein causes apolipoprotein B epitope change and enhances its uptake by macrophages. Biochim Biophys Acta 1992; 1126: 60-4.
44. 44. Clavey V, Lestavel-Delattre S, Copin C, Bard JM, Fruchart JC. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler Thromb Vasc Biol 1995; 15: 963-71.
45. 45. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Int Med 1992; 231: 25-30.
46. 46. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-6.
47. 47. Mykkanen L, Haffner SM, Rainwater DL, Karhapaa P, Miettinen H, Laakso M. Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 1997; 17: 1447-53.
48. 48. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol 1992; 70: 3H-9H.